Inventor · disambiguated record
Satyanarayana Chava
Also filed as: CHAVA SATYANARAYANA
36 granted patents·1 pending application·12 citations·filing 2002–2020
94Inventor score
Files withLAURUS LABS LTD18LAURUS LABS PRIVATE LTD8MATRIX LAB LTD4INDUKURI VENKATA SUNIL KUMAR2APTUIT LAURUS PRIVATE LTD1
Top patents by PatentIndex Score
37 records- 0180US9573902B2Process for the preparation of Ivacaftor and its intermediatesLAURUS LABS PRIVATE LTD·Filed 2014·Granted Feb 21, 2017·3 cites·23 claims
- 0279US10428053B2Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereofLAURUS LABS LTD·Filed 2016·Granted Oct 1, 2019·3 cites·20 claims
- 0379US9957234B2Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereofLAURUS LABS LTD·Filed 2015·Granted May 1, 2018·2 cites·52 claims
- 0474US8207343B2Process for preparing montelukast and salts thereofINDUKURI VENKATA SUNIL KUMAR·Filed 2009·Granted Jun 26, 2012·2 cites·23 claims
- 0572US10836753B2Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereofLAURUS LABS LTD·Filed 2019·Granted Nov 17, 2020·0 cites·3 claims
- 0671US10815202B2Process for the preparation of ivacaftorLAURUS LABS LTD·Filed 2019·Granted Oct 27, 2020·0 cites·13 claims
- 0771US8367834B2Process for preparing Montelukast and salts thereofLAURUS LABS PRIVATE LTD·Filed 2012·Granted Feb 5, 2013·1 cites·20 claims
- 0870US11414386B2Process for the preparation of ivacaftor and its intermediatesLAURUS LABS LTD·Filed 2020·Granted Aug 16, 2022·0 cites·41 claims
- 0967US11040961B2Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereofLAURUS LABS LTD·Filed 2019·Granted Jun 22, 2021·0 cites·8 claims
- 1067US10654872B1Polymorphs of dolutegravir and salts thereofLAURUS LABS LTD·Filed 2020·Granted May 19, 2020·0 cites·6 claims
- 1167US10647729B1Polymorphs of dolutegravir and salts thereofLAURUS LABS LTD·Filed 2020·Granted May 12, 2020·0 cites·10 claims
- 1265US11427570B2Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereofLAURUS LABS LTD·Filed 2020·Granted Aug 30, 2022·0 cites·38 claims
- 1365US11299477B2Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereofLAURUS LABS LTD·Filed 2020·Granted Apr 12, 2022·0 cites·14 claims
- 1464US10800809B2Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereofLAURUS LABS LTD·Filed 2019·Granted Oct 13, 2020·0 cites·13 claims
- 1563US10738038B2Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereofLAURUS LABS LTD·Filed 2019·Granted Aug 11, 2020·0 cites·7 claims
- 1663US10730859B2Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereofLAURUS LABS PRIVATE LTD·Filed 2014·Granted Aug 4, 2020·0 cites·17 claims
- 1763US10597404B2Polymorphs of dolutegravir and salts thereofLAURUS LABS LTD·Filed 2016·Granted Mar 24, 2020·0 cites·17 claims
- 1862US10626091B2Process for the preparation of enzalutamideLAURUS LABS LTD·Filed 2018·Granted Apr 21, 2020·0 cites·13 claims
- 1960US10501419B2Processes for the preparation of ivacaftorLAURUS LABS PRIVATE LTD·Filed 2016·Granted Dec 10, 2019·0 cites·14 claims
- 2058US10301321B2Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereofLAURUS LABS LTD·Filed 2017·Granted May 28, 2019·0 cites·21 claims
- 2157US9487487B2Process for preparation of montelukast sodiumLAURUS LABS PRIVATE LTD PLOT NO DS1·Filed 2013·Granted Nov 8, 2016·1 cites·19 claims
- 2253US10364269B2Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereofLAURUS LABS PRIVATE LTD·Filed 2016·Granted Jul 30, 2019·0 cites·31 claims
- 2353US9388113B2Salts of sitagliptin, process from the preparation and pharmaceutical composition thereforeLAURUS LABS PRIVATE LTD·Filed 2015·Granted Jul 12, 2016·0 cites·9 claims
- 2452US9181256B2Salts of sitagliptin, process for the preparation and pharmaceutical composition thereforeLAURUS LABS PRIVATE LTD·Filed 2012·Granted Nov 10, 2015·0 cites·2 claims
- 2548US2009143590A1Process for the Preparation of Montelukast and its SaltsMATRIX LAB LTD·Filed 2004·Application pending·0 cites
- 2647US9856271B2Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereofLAURUS LABS PRIVATE LTD·Filed 2015·Granted Jan 2, 2018·0 cites·29 claims
- 2747US7943784B2Process for the preparation of almotriptanMATRIX LAB LTD·Filed 2006·Granted May 17, 2011·0 cites·3 claims
- 2846US9056882B2Process for the preparation of tenofovirINDUKURI VENKATA SUNIL KUMAR·Filed 2012·Granted Jun 16, 2015·0 cites·20 claims
- 2945US10131636B2Process for the preparation of EnzalutamideLAURUS LABS LTD·Filed 2015·Granted Nov 20, 2018·0 cites·18 claims
- 3045US7884214B2Process for the preparation of TelmisartanMATRIX LAB LTD·Filed 2006·Granted Feb 8, 2011·0 cites·6 claims
- 3140US11066368B2Process for the preparation and particle size reduction of pirfenidoneLAURUS LABS LTD·Filed 2018·Granted Jul 20, 2021·0 cites·30 claims
- 3240US8791259B2Process for the preparation of TenofovirAPTUIT LAURUS PRIVATE LTD·Filed 2012·Granted Jul 29, 2014·0 cites·18 claims
- 3337US9650346B2Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereofINDUKURI VENKATA S·Filed 2012·Granted May 16, 2017·0 cites·9 claims
- 3434US9073817B2Efficient process to induce enantioselectivity in procarbonyl compoundsBOLLU RAVINDRA BABU·Filed 2012·Granted Jul 7, 2015·0 cites·2 claims
- 3533US10669264B2Process for the preparation of macitentanLAURUS LABS LTD·Filed 2016·Granted Jun 2, 2020·0 cites·11 claims
- 3626US8987525B2Process for the preparation of polyhydroxystilbene compounds by deprotection of the corresponding ethersDORWAL HARISH NIRANJANLAL·Filed 2012·Granted Mar 24, 2015·0 cites·20 claims
- 3726US7365216B2Process for the production of citalopramMATRIX LAB LTD·Filed 2002·Granted Apr 29, 2008·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Satyanarayana Chava files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →